FDA Approves New Drug

prescription bottle of pillsThe Food and Drug Administration (FDA) today approved Tyzeka
(telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a
serious viral infection that attacks the liver and can cause lifelong infection,
scarring of the liver (cirrhosis), and eventually liver cancer, liver failure,
and death. Tyzeka is a new molecular entity, which is a term used by the FDA to